HEMOCROMATOSIS: A CHANGING WORLD
Abstract
Due to major advances in the understanding of iron metabolism as well as in the biochemical, imaging, and genetic domains : i) The nosological framework of hemochromatosis (HC) encompasses not only HFE-HC, by far the most frequent HC form, but also non-HFE HC diseases which comprise essentially juvenile HC and the ferroportin disease. ii) The diagnostic approach has become totally non invasive, based on clinical, imaging and biological data. iii) The treatment remains, for most forms, based on venesections, but the innovative emerging therapeutic approach is represented by hepcidin supplementation.